Vineti is launching its cloud-based system to streamline company processes and accelerate patient access to cell and gene therapies.

Theranos and Walgreens have reached a tentative agreement to put the latter's breach-of-contract lawsuit to rest, WSJ sources say.

IBM and Baheal Pharmaceutical have moved quickly to expand their relationship and bring Watson for Genomics to China.

SerImmune, whose technology maps the human antibody repertoire, rounded up $8 million from Merck, Illumina Ventures and unnamed investors.

Stryker has agreed to acquire Novadaq, which specializes in fluorescence imaging systems, for $701 million.

ReWalk Robotics, which makes an exoskeleton for people with spinal cord injury, unveiled a soft version designed for stroke survivors.

PerkinElmer has agreed to buy Euroimmun Medical Laboratory Diagnostics for about $1.3 billion.

A Boston University-led team has created a cell-infused 3D-printed patch that could treat ischemia.

Merck KGaA has teamed up with J. Craig Venter’s HLI to identify biomarkers that suggest melanoma patients will respond to pimasertib.

Six years after Pfizer's landmark REMOTE trial, Parexel and Sanofi are revisiting the idea of using wearables in clinical trials.